WAKE FOREST UNIVERSITY HEALTH SCIENCES

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Supervised Exercise as a Therapeutic Strategy for Interstitial Cystitis/Bladder Pain Syndrome

Not Applicable

Recruiting

Conditions: Interstitial Cystitis
Bladder Pain Syndrome

Interventions: Behavioral: Exercise regimen

First Posted Date: 2023-01-26

Last Posted Date: 2024-10-26

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 10

Registration Number: NCT05699551

Locations: 🇺🇸
Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States

Quick Start Durvalumab Following Chemoradiation for Stage III Nonsmall Cell Lung Cancer

Phase 2

Recruiting

Conditions: Nonsmall Cell Lung Cancer Stage III
Unresectable Non-Small Cell Lung Carcinoma
Nonsmall Cell Lung Cancer, Stage II

Interventions: Drug: Durvalumab
Other: the EORTC Core Quality of Life Questionnaire (EORTC QLQ-C30)
Diagnostic Test: COPD Assessment Test (CAT)
Diagnostic Test: Modified Medical Research Council (mMRC) dyspnea scale

First Posted Date: 2023-01-25

Last Posted Date: 2024-11-13

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 28

Registration Number: NCT05696782

Locations: 🇺🇸
Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, North Carolina, United States

Tourette Discrimination (TD) Stigma Scale

Recruiting

Conditions: Tourette Syndrome in Children
Tourette Syndrome
Tics
Tourette Syndrome in Adolescence
Tic Disorder, Childhood

First Posted Date: 2023-01-25

Last Posted Date: 2024-11-27

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 135

Registration Number: NCT05696769

Locations: 🇺🇸
Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States

Reducing the Incidence of Symptomatic Brain Metastases With MRI Surveillance

Phase 2

Recruiting

Conditions: Nonsmall Cell Lung Cancer Stage III
Brain Metastases

Interventions: Diagnostic Test: MRI of the Brain
Other: Blood draws
Other: Quality of Life Questionnaires
Drug: Gadolinium

First Posted Date: 2023-01-20

Last Posted Date: 2024-06-14

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 60

Registration Number: NCT05692635

Locations: 🇺🇸
Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, North Carolina, United States

Pecto-intercostal Fascial Block (PIFB) for Postop Analgesia Following Sternotomy in Cardiac Surgery Patients

Phase 4

Completed

Conditions: Analgesia
Sternotomy

Interventions: Drug: Pecto-intercostal Fascial Block (PIFB)
Drug: PIFB with adjuvants

First Posted Date: 2023-01-09

Last Posted Date: 2024-06-11

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 31

Registration Number: NCT05676814

Locations: 🇺🇸
Wake Forest Health Sciences, Winston-Salem, North Carolina, United States

Implantation Of Vaginal Construct For Patients With Vaginal Aplasia

Phase 1

Recruiting

Conditions: Congenital Mullerian Duct Anomaly

Interventions: Biological: biologic vaginal-construct implantation

First Posted Date: 2023-01-09

Last Posted Date: 2024-10-26

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 10

Registration Number: NCT05675722

Locations: 🇺🇸
Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States

Prospective Evaluation of Intrathecal Targeted Drug Delivery for Cancer Associated Pain

Recruiting

Conditions: Chronic Pain
Neuropathic Pain
Cancer Pain
Cancer Associated Pain

Interventions: Device: Intrathecal Targeted Drug Delivery
Combination Product: Conservative medical management

First Posted Date: 2023-01-06

Last Posted Date: 2024-12-02

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 169

Registration Number: NCT05674240

Locations: 🇺🇸
Advocate Aurora Health, Oshkosh, Wisconsin, United States

NDPP-NextGen: A Clinical Trial to Reduce Intergenerational Obesity and Diabetes Risks

Not Applicable

Recruiting

Conditions: Overweight or Obesity

Interventions: Behavioral: NDPP-NextGen

First Posted Date: 2023-01-06

Last Posted Date: 2024-05-03

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 403

Registration Number: NCT05674799

Locations: 🇺🇸
Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States

A Pharmacokinetic Study of Intravenous and Intranasal Oxytocin in Healthy Subjects

Phase 1

Completed

Conditions: Healthy Volunteer Study

Interventions: Drug: intravenous oxytocin
Drug: intranasal oxytocin

First Posted Date: 2023-01-05

Last Posted Date: 2024-08-06

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 25

Registration Number: NCT05672667

Locations: 🇺🇸
Wake Forest Baptist Health, Winston-Salem, North Carolina, United States

Diltiazem in the Treatment of Atrial Fibrillation or Atrial Flutter With Rapid Ventricular Rate

Phase 4

Completed

Conditions: Atrial Fibrillation With Rapid Ventricular Response
Hypotension Drug-Induced

Interventions: Drug: Calcium pre-treatment
Other: Placebo

First Posted Date: 2022-12-22

Last Posted Date: 2024-12-02

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 92

Registration Number: NCT05661942

Locations: 🇺🇸
Advocate Christ Medical Center Emergency Department (ACMC ED), Oak Lawn, Illinois, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy